Evidence map›Paper›PMID 41473432›Full record

ArticleFrontiers in oncology2025

EnsembleSkinNet: a transfer learning-based framework for efficient skin cancer detection with explainable AI integration.

Srilakshmi Cherukuri, Srisailapu D Vara Prasad

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Srilakshmi CherukuriDepartment of Computer Science and Engineering, GITAM Deemed to be University, Hyderabad, India.
Srisailapu D Vara PrasadDepartment of Computer Science and Engineering, GITAM Deemed to be University, Hyderabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer remains to be one of the commonest and life-threatening cancers in the world, early diagnosis is vital for an effective treatment. Recent advances in deep learning, specifically Convolutional Neural Networks (CNNs), have led to remarkable progress in skin lesion classification by artificial intelligence. Although single CNN-based methods have been shown to provide high accuracies on their specific datasets and patient conditions, variations in lesion morphology, image quality, and acquisition settings can limit the generalization of these methods on a new unseen dataset. To overcome these difficulties, we present EnsembleSkinNet which is more explainable ensemble deep learning framework for skin image classification based on a softmax-weighted spectrum fusion of different pre-trained CNN architectures including Modified VGG16 (M-VGG16), ResNet50, Inception V3 and DenseNet201. Our framework improves the robustness and reliability by using transfer learning, fine-tuning, and Bayesian hyperparameter optimization for classification. For experimental evaluation using five-fold cross-validation in HAM10000 dataset, it achieves an accuracy of 98.32 ± 0.41%, precision = 98.20 ± 0.35%, recall = 98.10 ± 0.38%, and F1-score = 98.15 ± 0.37%. Cross-domain generalization was also demonstrated by obtaining an excellent external validation accuracy of 96.84 ± 0.42% and AUC = 0.983 on the ISIC 2020 dataset. Additionally, the Grad-CAM-based explainability analysis reached a mean Explainability Accuracy of 93.6% (k = 0.87), indicating agreement with dermatologist annotations. Clinically, this means that false negatives for melanoma and basal cell carcinoma were measurable less, so more cases are caught early and diagnostically driven confidence improved. Hence, EnsembleSkinNet presents a simple, reproducible, interpretable, and clinically adopted framework for OA compliant robust AI-based skin cancer diagnosis.

Indexed as

convolutional neural networks (CNNs)deep learningensemble learningexplainable AIskin cancer detectiontransfer learning

Identifiers

PMID41473432
PMCPMC12745442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.